Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reducing capsular thickness and enhancing angiogenesis around implant drug release systems.

Literature DB >> 11772462

Reducing capsular thickness and enhancing angiogenesis around implant drug release systems.

Abstract

Biological encapsulation and the foreign body reaction can impair the performance of implanted drug release devices. In this article, the classic definition of biocompatibility is questioned. Examples are presented of biomaterials showing unique healing behavior. A new paradigm for biomaterials healing is proposed in which non-specific protein adsorption is inhibited and matricellular proteins are controlled at the surfaces of implants.

Mesh：

Substances：

Year: 2002 PMID： 11772462 DOI： 10.1016/s0168-3659(01)00502-8

Source DB: PubMed Journal: J Control Release ISSN： 0168-3659 Impact factor: 9.776

Keyword Cloud
Cited

67 in total

1. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

Authors: Hironobu Takahashi; Yuwei Wang; David W Grainger
Journal: J Control Release Date: 2010-08-19 Impact factor: 9.776

2. Prevascularized silicon membranes for the enhancement of transport to implanted medical devices.

Authors: Kristan S Worthington; Luke A Wiley; Robert F Mullins; Budd A Tucker; Eric Nuxoll
Journal: J Biomed Mater Res B Appl Biomater Date: 2015-08-28 Impact factor: 3.368

Review 3. Advances in Biomaterials for Drug Delivery.

Authors: Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal: Adv Mater Date: 2018-05-07 Impact factor: 30.849

4. Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.

Authors: Thomas H Barker; Paul Framson; Pauli A Puolakkainen; May Reed; Sarah E Funk; E Helene Sage
Journal: Am J Pathol Date: 2005-03 Impact factor: 4.307

5. Reduced foreign body response at nitric oxide-releasing subcutaneous implants.

Authors: Evan M Hetrick; Heather L Prichard; Bruce Klitzman; Mark H Schoenfisch
Journal: Biomaterials Date: 2007-08-02 Impact factor: 12.479

6. Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.

Authors: Pim-on Rujitanaroj; Brian Jao; Junghoon Yang; Feng Wang; James M Anderson; Jun Wang; Sing Yian Chew
Journal: Acta Biomater Date: 2012-10-02 Impact factor: 8.947

Reducing capsular thickness and enhancing angiogenesis around implant drug release systems.

1. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

2. Prevascularized silicon membranes for the enhancement of transport to implanted medical devices.

Review 3. Advances in Biomaterials for Drug Delivery.

4. Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.

5. Reduced foreign body response at nitric oxide-releasing subcutaneous implants.

6. Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.

Review 7. Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.

8. Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.

9. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9.

Review 10. Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery.